Tatva Chintan Pharma Chem Limited (TATVA.NS) NSE
1,219.20
+4.8(+0.40%)
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
1,219.20
+4.8(+0.40%)
Currency In INR
| Market Cap | 24.61B |
| Enterprise Value | 25.73B |
| P/E Ratio | 67.85 |
| PEG Ratio | 0.11 |
| Price/Sales Ratio | 5.64 |
| Price/Book Ratio | 3.65 |
| Enterprise/Revenue | 5.86 |
| Enterprise/EBITDA | 30.53 |
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.08 |
| Operating Margin | 0.11 |
| Return On Assets | 0.04 |
| Return On Equity | 0.06 |
| Revenue | 5.06B |
| Revenue/Share | 216.14 |
| Gross Profit | 1.82B |
| EBITDA | 931.58M |
| Net Income | 420.54M |
| Diluted EPS | 17.98 |
| Total Cash | 87.91M |
| Total Cash/Share | 3.76 |
| Total Debt | 1.2B |
| Total Debt/Equity | 0.15 |
| Current Ratio | 1.64 |
| Book Value Per Share | 334.03 |
| 52-Week Change | 30.61 |
| 52-Week High | 1,610 |
| 52-Week Low | 886 |
| Moving Average 50 Days | 1,229.22 |
| Moving Average 200 Days | 1,245.77 |
| Average Volume | 55,146 |
| Shares Outstanding | 23.39M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 1 |
| Trailing Annual Dividend Yield | 0.08 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |